NanoPalm is a DeepTech company revolutionizing in-vivo gene therapies for genetic diseases with an advanced Lipid Nanoparticle (LNP) manufacturing process to create stable LNPs that can self-target specific organs and cells without the downsides of current LNP-based therapies.
| Website | https://nanopalm.ltd/ |
| Employees | 11 (10 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Lipid Nanoparticles, Gene Therapy, Nanoparticle Technology, Biotechnology, Nanomedicine, Genetic Diseases, Targeted Drug Delivery, Therapeutic Nanoparticles, Drug Delivery, Deeptech, Pharmaceutical, Advanced Therapeutics, Precision Medicine |
Looking for a particular NanoPalm employee's phone or email?
Ali Alhasan is the Founder and CEO of NanoPalm.
10 people are employed at NanoPalm.
NanoPalm is based in Riyadh, Riyadh Province.